EPCAM (Epithelial Cell Adhesion Molecule) was initially identified asa tumor antigen in colorectal carcinomas and serves as a prognosticmarker for disseminated tumor cells, which are considered the majorsource for metastatic cancer cells.63 Itshigh expression in bone cells has been reported rarely. This evidence concerns the gene EPCAM and metastatic malignant neoplasm.